Back to top
more

Baxter International (BAX)

(Delayed Data from NYSE)

$35.97 USD

35.97
6,376,897

-0.94 (-2.55%)

Updated Oct 2, 2024 04:00 PM ET

After-Market: $35.97 0.00 (0.00%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Can Strategic Alliances Aid LabCorp's (LH) Q2 Earnings?

LabCorp (LH) is expected to gain traction from a solid LabCorp Diagnostics segment in Q2, courtesy of a favorable price, mix, tuck-in acquisitions and organic volume.

    Sreyoshi Mukherjee headshot

    Trump's APAC Focus Puts Spotlight on These 3 MedTech Stocks

    Despite the trade war upheaval in Asia, some medical device companies stand strong in the APAC region.

      AngioDynamics (ANGO) Misses Q4 Earnings & Revenue Estimates

      AngioDynamics (ANGO) misses Q4 earnings and revenue estimates; international sales high.

        Can International Sales Drive Baxter's (BAX) Q2 Earnings?

        Baxter's (BAX) Q2 earnings likely to be aided by promising international ventures and acquisitions; cyclophosphamide competition raises concern.

          Here's Why You Should Invest in Baxter (BAX) Stock Right Now

          Baxter's (BAX) raised 2018 guidance and strong international presence make it a lucrative pick.

            HRC or BAX: Which Is the Better Value Stock Right Now?

            HRC vs. BAX: Which Stock Is the Better Value Option?

              Stryker or Baxter: Which is a Better Pick for Your Portfolio?

              Stryker (SYK) and Baxter's (BAX) strong expected growth rates and rising share price make them close contenders in the MedTech industry.

                5 Stocks Near 52-Week High: Is More Upside in the Cards?

                Here are some stocks trading near their 52-week high levels with potential to scale higher.

                  BSX or BAX: Which is a Better Pick for Your Portfolio Now?

                  After considering various parameters and fundamentals, we help you make a choice between Boston Scientific (BSX) and Baxter (BAX).

                    Zacks.com highlights: Jazz Pharmaceuticals, Baxter International, Boise Cascade, Insight Enterprises and Comfort Systems USA

                    Zacks.com highlights: Jazz Pharmaceuticals, Baxter International, Boise Cascade, Insight Enterprises and Comfort Systems USA

                      5 Stocks Near 52-Week High With More Room to Run

                      Here are some stocks trading near their 52-week high levels and still with plenty of room for upside.

                        Baxter (BAX) Soars to a 52-Week High, Time to Cash Out?

                        Baxter International Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for BAX for clues.

                          Cooper Companies (COO) Q2 Earnings & Revenues Beat Estimates

                          Cooper (COO) witnesses strong growth across segments and geographies in fiscal Q2.

                            Here's Why You Should Invest in Baxter International Now

                            Strategic buyouts consistently help Baxter (BAX) gain market traction. Recently, the company completes the consolidation of both RECOTHROM and PREVELEAK.

                              Zacks.com featured highlights include: Schweitzer-Mauduit, Insight, Baxter, Boise Cascade and Comfort Systems

                              Zacks.com featured highlights include: Schweitzer-Mauduit, Insight, Baxter, Boise Cascade and Comfort Systems

                                5 Stocks Near 52-Week High With Potential to Scale Higher

                                Here are some stocks trading near their 52-week high levels and still with plenty of room for upside.

                                  Nabaparna Bhattacharya headshot

                                  US-North Korea Summit Talks Resume: 4 MedTech Stocks to Watch

                                  Here we take a look at four leading MedTech players that are gaining from opportunities in the APAC market

                                    Baxter International (BAX) Hits a 52-Week High, Can the Run Continue?

                                    Baxter International Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for BAX for clues.

                                      Baxter International (BAX) Up 3.5% Since Earnings Report: Can It Continue?

                                      Baxter International (BAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                        Medtronic (MDT) Q4 Earnings Beat on Growth in All Lines

                                        All major business groups of Medtronic (MDT) contribute to solid top-line growth at CER, which highlighted sustainability across groups and regions.

                                          BioScrip's Core Business Strong Despite Reimbursement Issues

                                          BioScrip (BIOS) consistently advances with its multi-faceted CORE plan to perk up the money matters. However, reimbursement cuts pertaining to 21st century Cures Act might hinder growth in 2018.

                                            Zacks.com highlights: Schweitzer-Mauduit International, Insight Enterprises, Baxter International, Fortinet and Comfort Systems USA

                                            Zacks.com highlights: Schweitzer-Mauduit International, Insight Enterprises, Baxter International, Fortinet and Comfort Systems USA

                                              Baxter (BAX) Gets FDA Nod for Spectrum IQ, Secures Infusions

                                              Baxter (BAX) streamlines EMR integration for patients through FDA's approval of Spectrum IQ.

                                                GNC Holdings' Global Prospects Solid, Competition Stiff

                                                GNC Holdings (GNC) progresses with deals to boost international presence.

                                                  CryoLife (CRY) Stock Gains 9.5% on Impressive Q1 Earnings

                                                  CryoLife's (CRY) shares gain on growth in all product lines along with strong performance in all geographies in Q1.